KORU CFO reports RSU vesting, tax withholding

KORU Medical Systems Chief Financial Officer Thomas Edward Adams reported routine equity compensation activity involving restricted stock units.

Rhea-AI Filing Summary

KORU Medical Systems Chief Financial Officer Thomas Edward Adams reported routine equity compensation activity involving restricted stock units. On May 14, 2026, common stock was issued upon vesting of RSUs, each unit representing a contingent right to receive one share of common stock upon vesting.

In connection with this vesting, 2,900 shares of common stock were disposed of at $3.94 per share to satisfy tax obligations, while 8,193 shares were acquired through a derivative exercise/conversion. Following these transactions, Adams directly holds 313,440 shares of KORU Medical common stock. These are not open-market buy or sell transactions but compensation-related events.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Adams Thomas Edward

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Exercise	Common Stock	8,193	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	2,900	$3.94	$11K

Holdings After Transaction: Common Stock — 313,440 shares (Direct)

Footnotes (2)

1. F1. Represents common stock issued upon vesting of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock upon vesting.
2. F2. Represents shares withheld to satisfy tax obligations upon vesting of restricted stock units.

Key Figures

Tax-withheld shares: 2,900 shares at $3.94 Shares from RSU vesting: 8,193 shares Post-transaction holdings: 316,340 shares

3 metrics

Tax-withheld shares 2,900 shares at $3.94 Shares withheld to satisfy tax obligations on RSU vesting

Shares from RSU vesting 8,193 shares Common stock issued upon vesting of restricted stock units

Post-transaction holdings 316,340 shares Direct common stock holdings after reported transactions

Key Terms

restricted stock units, contingent right, tax obligations

3 terms

restricted stock units financial

"Represents common stock issued upon vesting of restricted stock units."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"Each restricted stock unit represents a contingent right to receive one share of common stock upon vesting."

tax obligations financial

"Represents shares withheld to satisfy tax obligations upon vesting of restricted stock units."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did KORU Medical (KRMD) CFO Thomas Adams report in this Form 4?

KORU Medical CFO Thomas Adams reported RSU vesting-related transactions. Common stock was issued upon RSU vesting, with additional shares withheld to cover tax obligations, updating his direct common stock holdings as disclosed in the filing.

How many KORU Medical (KRMD) shares were withheld for taxes for the CFO?

The Form 4 shows 2,900 KORU Medical common shares were disposed of at $3.94 per share. These shares were withheld specifically to satisfy tax obligations arising from the vesting of restricted stock units granted to the CFO.

How many KORU Medical (KRMD) shares did the CFO acquire through RSU vesting?

The Form 4 reports that 8,193 KORU Medical common shares were acquired by the CFO. These shares came from restricted stock units that vested, with each RSU converting into one share of common stock upon vesting.

What are the CFO’s KORU Medical (KRMD) holdings after these transactions?

After the RSU vesting and tax-withholding disposition, the CFO’s direct holdings total 316,340 KORU Medical common shares. This figure reflects his position immediately following the reported compensation-related transactions on the stated date.

Were the KORU Medical (KRMD) CFO’s transactions open-market buys or sells?

The transactions were not open-market trades. Shares were issued upon vesting of restricted stock units, and 2,900 shares were withheld to cover tax obligations. These are routine compensation-related events rather than discretionary market purchases or sales.

What does RSU vesting mean for KORU Medical (KRMD) insiders like the CFO?

RSU vesting means previously granted restricted stock units convert into common shares once conditions are met. For the CFO, vested RSUs resulted in common stock issuance and associated tax withholding, aligning part of his compensation with KORU Medical’s equity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/18/2026 - 04:33 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Adams Thomas Edward

(Last) (First) (Middle)

C/O KORU MEDICAL SYSTEMS, INC.

100 CORPORATE DRIVE

(Street)

MAHWAH NEW JERSEY 07430

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
KORU Medical Systems, Inc. [ KRMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/14/2026		M		8,193	A	$0(1)	316,340	D
Common Stock	05/14/2026		F(2)		2,900	D	$3.94	313,440	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents common stock issued upon vesting of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock upon vesting.

2. Represents shares withheld to satisfy tax obligations upon vesting of restricted stock units.

Remarks:

The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person.

	/s/ Thomas Edward Adams	05/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)